Table 1.
Federal Drug Administration approvals of artificial intelligence (AI) applications relevant for cardiology practice
Year | Company | AI application |
---|---|---|
2014 | Alivecor | Detection of atrial fibrillation |
2016 | Lumify | Ultrasound image diagnosis |
2017 | Arterys | Cardiac MRI ventricle segmentation |
2017 | Bioflux | Detecting arrhythmias |
2017 | Cardiologs | ECG analysis |
2018 | Lepu Medical | ECG analysis |
2018 | Zebra Medical Vision | Automated coronary artery calcification |
2018 | Physiq Heart Rhythm Module | Detection of atrial fibrillation |
2018 | Apple | Detection of atrial fibrillation |
2018 | Bay Labs | Echocardiogram analysis |
2019 | Verily | ECG feature on Study Watch |
2019 | Alivecor | Six-lead smartphone ECG |
2019 | Zebra Medical Vision | Radiographic diagnosis |
2019 | Aidoc | Flagging pulmonary embolism |